Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects Persist
Clinical Infectious Diseases · 2025
DOI: 10.1093/cid/ciaf060 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Clinical Infectious Diseases, 2025. Verfasst von Annette Fox und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza A Virus, H3N2 Subtype, Antibodies, Viral, Influenza, Human. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Grants Committee of Hong Kong, US Centers for Disease Control and Prevention, Research Grants Council of the Hong Kong Special Administrative Region.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Background
Influenza vaccine effectiveness can be reduced in older adults and among repeatedly vaccinated groups. Results from year 1 of “PIVOT,” a randomized trial among adults aged ≥65 years in Hong Kong, showed that adjuvanted (Adj), high-dose (HD), and recombinant hemagglutinin (rHA) vaccines induced greater antibody responses against vaccine viruses than standard-dose (SD) influenza vaccine. Here, we examine the breadth of A(H3N2)-reactive antibodies induced during the first 2 study years (2017/2018, 2018/2019), and compare participants who received influenza vaccination annually, or not at all, for 5 years preceding enrollment.
Methods
14–20 PIVOT participants per vaccine and prior vaccination group (0/5 or 5/5 prior years) who provided sera on days 0, 30, and 182 in year 1 and days 0 and 30 in year 2 were assessed. Hemagglutination inhibition (HAI) antibody titers were measured against 30 viruses spanning 1968 to 2018.
Results
In year 1, rHA and Adj but not HD vaccines induced titers ≥40 and titer rises ≥4-fold (seroconversion) against significantly more strains than SD vaccine among participants vaccinated 0/5 prior years. Only rHA and Adj vaccines induced titers ≥40 against post-vaccine strains. Antibody responses were poor among participants vaccinated 5/5 compared with 0/5 prior years and only rHA increased the breadth of seroconversion compared with the SD vaccine in this group. Antibody responses were weaker across groups in year 2.
Conclusions
The results suggest that Adj and particularly rHA vaccines may improve the breadth of protection against A(H3N2) viruses but may not overcome attenuating effects of repeated vaccination in older adults. Clinical Trials Registration NCT03330132
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
- Victorian Infectious Diseases Reference Laboratories, at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
- School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
- Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Influenza Division, Atlanta, Georgia, USA.
- HKU-Pasteur Research Pole, School of Public Health, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
- Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, Australia.
ORCID-Profile: Annette Fox, Stephany Sánchez-Ovando, Faith Ho, Min Z Levine, Benjamin J Cowling, Nancy H L Leung
Förderung
- University Grants Committee of Hong Kong
- US Centers for Disease Control and Prevention
- Research Grants Council of the Hong Kong Special Administrative Region
- Health and Medical Research Fund
- Health Bureau of the Hong Kong Special Administrative Region
- NIAID NIH HHS
- Australian Government Department of Health
- Theme-based Research Scheme
Zitieren
APA
Fox, A., Sánchez-Ovando, S., Carolan, L., Hadiprodjo, A. J., Chen, Y., Ho, F., Cheng, S. M. S., Thompson, M. G., Iuliano, A. D., Levine, M. Z., Valkenburg, S. A., Ip, D. K. M., Peiris, J. S. M., Sullivan, S. G., Cowling, B. J., & Leung, N. H. L. (2025). Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects Persist. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciaf060
Vancouver
Fox A, Sánchez-Ovando S, Carolan L, Hadiprodjo AJ, Chen Y, Ho F, et al. Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects Persist. Clinical Infectious Diseases. 2025. doi:10.1093/cid/ciaf060
BibTeX
@article{Fox2025,
author = {Fox, Annette and Sánchez-Ovando, Stephany and Carolan, Louise and Hadiprodjo, A Jessica and Chen, Yuyun and Ho, Faith and Cheng, Samuel M S and Thompson, Mark G and Iuliano, A Danielle and Levine, Min Z and Valkenburg, Sophie A and Ip, Dennis K M and Peiris, J S Malik and Sullivan, Sheena G and Cowling, Benjamin J and Leung, Nancy H L},
title = {Enhanced Influenza Vaccines Extend A(H3N2) Antibody Reactivity in Older Adults but Prior Vaccination Effects Persist},
journal = {Clinical Infectious Diseases},
year = {2025},
doi = {10.1093/cid/ciaf060}
}
EUVIMED